Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 8, Issue 12, 2010, Pages

[No Author Info available]

Author keywords

Actimel ; antibiotic treatment; Clostridium difficile toxin; diarrhoea; elderly; fermented milk; intestine; Lactobacillus casei DN 114 001; Lactobacillus delbrueckii subsp. bulgaricus; microbiota; risk reduction; Streptococcus thermophilus; yoghurt

Indexed keywords

EID: 84879785616     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2010.1903     Document Type: Article

References (29)

1. Barbut F and Petit JC, 2001. Epidemiology of Clostridium difficile-associated infections. Clinical Microbiology and Infection;7:405–10.
2. Bulpitt CJ, 2009, study report, unpublished. Study (2000–2001) of a probiotic Lactobacillus preparation in the prevention of antibiotic-associated diarrhoea.
3. Bulpitt CJ and Hickson M, 2010, study report, unpublished. Use of probiotic Lactobacillus reparation to prevent diarrhoea associated with AB: randomised double blind control controlled trial. Version 1.3 - of 28 May 2010.
4. Danone, 2009. Dossier submitted on a health claim application on fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®) and “decreases presence of Clostridium difficile toxins in the gut of susceptible ageing people” pursuant to Article 14 of Regulation (EC) No 1924/2006 (Claim serial No: 0260_FR). September 2009. Submitted by Danone France.
5. Danone Research, 2010. Unpublished summary report on the antimicrobial activity of L. casei DN-114001 and other lactobacilli strains from Danone's strain collection.
6. Diancourt L, Passet V, Chervaux C, Garault P, Smokvina T and Brisse S, 2007. Multilocus sequence typing of Lactobacillus casei reveals a clonal population structure with low levels of homologous recombination. Applied and Environmental Microbiology, 73, 6601–6611.
7. Djouzi Z, Andrieux, C, Degivry M-C, Bouley C, Szylit O, 1997. The association of yoghurt starters with Lactobacillus casei DN-114 001 in fermented milk alters the composition and metabolism of intestinal microflora in germ-free rats and in human flora-associated rats. Journal of Nutrition, 127, 2260–2266.
8. D'Souza AL, Rajkumar C, Walters J, Rogers T, Bulpitt C, 2003. Unpublished protocol for the study of a probiotic Lactobacillus preparation in the prevention of antibiotic-associated diarrhea (study protocol of the “Hickson Study”).
9. Freitas M, Tavan E, Cayuela C, Diop L, Sapin C., Trugnan G, 2003. Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Scientiae forum – Models and Speculations. Biology of the Cell, 95 503–506.
10. Guerin-Danan C, Chabanet C, Pedone C, Popot F, Vaissade P, Bouley C, Szylit O, Andrieux C, 1998. Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants. American Journal of Clinical Nutrition, 67, 111–117.
11. Guerin-Danan C, Meslin JC, Chambard A, Charpilienne A, Relano P, Bouley C, Cohen J, Andrieux C, 2001. Food Supplementation with Milk Fermented by Lactobacillus casei DN-114 001 Protects Suckling Rats from Rotavirus-Associated Diarrea. Journal of Nutrition, 131(1): 111–117.
12. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J, 2010. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. British Journal of Nutrition;103(1):58–68.
13. Guimaraes V, Mater DDG, Furet JP, Goupil-Feuillerat N, Combrisson J, Langella P, Smokvina T, Corthier G, Oozeer R, 2010. Impact of the human gut on Lactobacillus casei DN-114 001 gene expression 2010. Unpublished manuscript.
14. Hickson M, D'Souza AL, Rajkumar C, Bulpitt CJ, Muthu N, Rogers TR and Want S, 2007. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with AB: randomised double blind control controlled trial. British Medical Journal, 335, 80–83.
15. Houlder SL, Sivapathasuntharam D, Tangiisuran B, Wright J, Rajkumar C, 2009. Unpublished study report on probiotics for the prevention of Clostridium difficile acquisition in an elderly inpatient population.
16. Ingrassia I, Leplingard A, Darfeuille-Michaud A, 2005. Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells Applied and Environmental Microbiology;71(6):2880–7.
17. JCICSB (Judicial Commission of the International Committee on Systematics of Bacteria), 2008. The type strain of Lactobacillus casei is ATCC 393, ATCC 334 cannot serve as the type because it represents a different taxon, the name Lactobacillus paracasei and its subspecies name are not rejected and the revival of the name ‘Lactobacillus zeae'contravenes Rules 51b (1) and (2) of the International Code of Nomenclature of Bacteria. Opinion 82. International Journal of Systematic and Evolutionary Microbiology, 58, 1764–1765.
18. Karlström O, Fryklund B, Tullus K, Burman LG, 1998. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clinical Infectious Diseases, 26, 141–145.
19. Kuijper EJ and Van Dissel JT, 2008. Spectrum of Clostridium difficile infections outside health care facilities. CMAJ; 179(8):747–8.
20. McFarland LV, 2008. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiologia, 3, 563–578.
21. Medici M, Vinderola CG, Weill R, Perdigón G, 2005. Effect of fermented milk containing probiotic bacteria in the prevention of an enteroinvasive Escherichia coli infection in mice. Journal of Dairy Research, 72(2):243–9.
22. Niborski V, Wang XF, Tanguy J, Borgiès B, Jost D, Ernouf C, Le Dreff P, Clément-Bollé C, Heyer V. (2009). Unpublished manuscript abstract: Consumption of a fermented dairy drink containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of common infectious disease and improves quality of life in adults exposed to a multi-stressor situation: randomised, double-blind, placebo-controlled trial.
23. Oozeer R, Goupil-Feuillerat N, Alpert CA, Van de Guchte M, Anba J, Mengaud J and Corthier G, 2002. Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Applied and Environmental Microbiology 68, 3570–3574.
24. Oozeer R, Mater DD, Goupil-Feuillerat N and Corthier G, 2004. Initiation of protein synthesis by a labeled derivative of the Lactobacillus casei DN-114 001 strain during transit from the stomach to the cecum in mice harboring human microbiota. Appl Environ Microbiol 70, 6992–6997.
25. Oozeer, R.; Leplingard, A.; Mater, D.D.; Mogenet, A.; Michelin, R.; Seksek, I.; Marteau, P.; Dore, J.; Bresson, J-L. and Corthier, G., 2006. Survival of lactobacillus casei in the human digestive tract after consumption of fermented milk. Applied and Environmental Microbiology, 72, 5615–5617.
26. Parassol N, Freitas M, Thoreux K, Dalmasso G, Bourdet-Sicard R and Rampal P, 2005. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Research in Microbiology, 156, 256–262.
27. Rochet V, Rigottier-Gois L, Sutren M, Krementscki M-N, Anderieux C, Furet J-P, Tailliez P, Levenez F, Mogenet A, Bresson J-L, Meance S, Cayuela C, Leplingard A and Dore J, 2006. Effects of orally administered lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans. British Journal of Nutrition, 95, 421–429.
28. Rochet V, Rigottier-Gois L, Levenez F, Cadiou J, Marteau P, Bresson JL, Goupil-Feillerat N and Doré J, 2008. Modulation of Lactobacillus casei in ileal and fecal samples from healthy volunteers after consumption of a fermented milk containing Lactobacillus casei DN-114 001Rif. Canadian Journal of Microbiology, 54, 660–667.
29. Wistrom J, Norrby SR, Myhre EB, Eriksson S, Granstrom G, Lagergren L, Englund G, Nord CE, Svenungsson B, 2001. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. Journal of Antimicrobial Chemotherapy, 47(1):43–50. jac.oxfordjournals.org/cgi/reprint/47/1/43.pdf.